12:00 AM
Oct 21, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Cynvenio Biosystems sales and marketing update

Cynvenio launched worldwide its ClearID monitoring program for early detection of breast cancer recurrence. The program, which uses blood samples that are analyzed at the company's CLIA-certified laboratory,...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >